Clinical Trials on Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
Total 501 results
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedDouble Vaccinated for COVID-19 (For Phase 1 of the Study) | Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)Canada
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
Saint Francis CareCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | CoronavirusUnited States
-
University Hospital, Basel, SwitzerlandCompletedSevere-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)Switzerland
-
ANRS, Emerging Infectious DiseasesRecruitingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)France, Martinique
-
University of PecsHungarian Ministry of Innovation and TechnologyTerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Hungary
-
Cogna Technology Solutions LLCNovavaxCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)United Arab Emirates
-
Goethe UniversityNationwide Network of University Medicine (NUM) on Covid-19RecruitingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Germany
-
AbbVieCompletedSevere Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)United States
-
Oneness Biotech Co., Ltd.CompletedDisease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)United States
-
Grifols Therapeutics LLCTerminatedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionSpain
-
AUVAParacelsus Medical UniversityCompletedCoronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2Austria
-
Gérond'ifCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)France
-
Inovio PharmaceuticalsAdvaccine (Suzhou) Biopharmaceuticals Co., Ltd.TerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 DiseaseUnited States, Mexico, Colombia
-
National Institute of Allergy and Infectious Diseases...PPD; University of Washington; Vanderbilt University Medical Center; Implicit BioscienceTerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19)United States
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
Hôpital Universitaire SahloulCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | a Randomized Double-blind Study | PHYTOTHERAPIETunisia
-
Hospices Civils de LyonCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Infection, CoronavirusFrance
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
University Hospital of FerraraActive, not recruitingSevere Acute Respiratory Syndrome Coronavirus 2Italy
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...CompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)United States
-
Pulmoquine Therapeutics, IncRockefeller UniversityCompletedSevere Acute Respiratory Syndrome Coronavirus 2United States
-
Jena University HospitalCompletedSevere Acute Respiratory Syndrome Coronavirus 2Germany
-
South African National Blood ServiceUnknownTherapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19COVID-19 | SARS-CoV-2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2South Africa
-
Imam Abdulrahman Bin Faisal UniversityDammam Medical Complex; Institute for Research and medical consultations (IRMC)UnknownHospitalized Patients | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection) | Laboratory-confirmed SARS-CoV 2 InfectionSaudi Arabia
-
Rennes University HospitalUnknownARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2 | Acute Refractory Heart Failure Related to SARS-CoV 2France
-
PfizerWithdrawnSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Immunocompromised | Hospitalization | Child, HospitalizedUnited States, Bulgaria
-
Pomeranian Medical University SzczecinNot yet recruitingOxygen Deficiency | Corona Virus Infection | ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2Poland
-
ChimerixTerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Acute Lung Injury | Coronavirus Disease 2019 (COVID-19)United States
-
Centre Hospitalier Intercommunal de Toulon La Seyne...CompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)France
-
Laboratorios Silanes S.A. de C.V.WithdrawnMetabolic Syndrome | Type 2 Diabetes | Severe Acute Respiratory Syndrome Coronavirus 2Mexico
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedSevere Acute Respiratory Syndrome Coronavirus 2Canada
-
University of Cape TownUniversity of KwaZuluUnknownSevere Acute Respiratory Syndrome Coronavirus 2South Africa
-
Walid HABRECompletedElectric Impedance | Severe Acute Respiratory Syndrome Coronavirus 2 | Prone PositioningSwitzerland
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompleted
-
University of SaskatchewanGovernment of Canada; Government of SaskatchewanWithdrawnSevere Acute Respiratory Syndrome Coronavirus 2
-
Laboratorios Silanes S.A. de C.V.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Mexico
-
Vanderson Geraldo RochaTerminatedSARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus 2Brazil
-
U.S. Army Medical Research and Development CommandNo longer availableTreatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)Severe Acute Respiratory Syndrome Coronavirus 2United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
William Beaumont HospitalsCompletedCOVID-19 | Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2United States
-
Central Hospital, Nancy, FranceCompletedARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2France
-
Ophirex, Inc.Premier Research Group plcTerminatedCoronavirus Disease 2019 | Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2United States
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
Pontificia Universidad Catolica de ChileFundacion Arturo Lopez PerezCompletedSevere Acute Respiratory Syndrome Coronavirus 2Chile
-
Elizabeth Glaser Pediatric AIDS FoundationFind; Kiambu CountyCompletedSevere Acute Respiratory Syndrome Coronavirus 2 InfectionKenya
-
NovavaxNot yet recruitingSevere Acute Respiratory Syndrome Coronavirus 2 Infection
-
Hospital Universitario San IgnacioPontificia Universidad Javeriana; Hospital Universitario Nacional de Colombia; Hospital de la Samaritana, Sede Bogotá y Sede Zipaquirá and other collaboratorsUnknownCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2
-
University of California, San FranciscoRowpar Pharmaceuticals, Inc.TerminatedCoronavirus Infections | COVID-19 | SARS-CoV 2 | Pharyngeal Diseases | Severe Acute Respiratory Syndrome Coronavirus 2 | Virus DiseaseUnited States
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsRecruitingCovid19 | SARS-CoV2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Covid19 Drug TreatmentBurkina Faso, Guinea
-
Asan Medical CenterSuspendedCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19Korea, Republic of